Ligand validation:6LG9

ECU: 2-azanyl-7-bromanyl-4-imidazol-1-yl-quinolin-8-ol

ECU is a Ligand Of Interest in 6LG9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LG9_ECU_A_201	91%	28%	0.092	0.979	1.6	1.45	4	5	0	0	100%	0.9847

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.